Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1038

1.

Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.

Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, Norton L, Tan LK.

Am J Surg Pathol. 2005 Nov;29(11):1482-9. Erratum in: Am J Surg Pathol. 2006 Jan;30(1):140.

PMID:
16224215
2.

Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?

Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Yoshikawa K, Sato Y, Aoyama H, Hayashi T, Kushima R.

Hum Pathol. 2008 May;39(5):666-71. doi: 10.1016/j.humpath.2007.09.009. Epub 2008 Mar 12.

PMID:
18339419
4.
5.

The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.

Lee AH, Paish EC, Marchio C, Sapino A, Schmitt FC, Ellis IO, Reis-Filho JS.

Histopathology. 2007 Dec;51(6):824-8.

PMID:
18042071
6.

Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.

Han L, Pansare V, Al-Abbadi M, Husain M, Feng J.

Diagn Cytopathol. 2010 May;38(5):333-6. doi: 10.1002/dc.21202.

PMID:
19856421
7.
8.

Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.

Kanner WA, Galgano MT, Stoler MH, Mills SE, Atkins KA.

Int J Gynecol Pathol. 2008 Oct;27(4):491-5. doi: 10.1097/PGP.0b013e31817d5340.

PMID:
18753974
9.

WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.

Lee BH, Hecht JL, Pinkus JL, Pinkus GS.

Am J Clin Pathol. 2002 May;117(5):745-50.

PMID:
12090423
10.

Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.

Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.

Diagn Cytopathol. 2009 Jul;37(7):475-8. doi: 10.1002/dc.21039.

PMID:
19217055
11.
12.

Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.

Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF.

Hum Pathol. 2000 Jun;31(6):672-7.

PMID:
10872659
13.

GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.

Wang LJ, Greaves WO, Sabo E, Noble L, Tavares R, Ng T, DeLellis RA, Resnick MB.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.

PMID:
19620839
14.

CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.

Keen CE, Szakacs S, Okon E, Rubin JS, Bryant BM.

Histopathology. 1999 Feb;34(2):113-7.

PMID:
10064389
15.

Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.

Nonaka D, Chiriboga L, Soslow RA.

Am J Surg Pathol. 2008 Oct;32(10):1566-71. doi: 10.1097/PAS.0b013e31816d71ad.

PMID:
18724243
16.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
18.

Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.

Zhao C, Bratthauer GL, Barner R, Vang R.

Am J Surg Pathol. 2007 Sep;31(9):1378-86.

PMID:
17721194
19.

MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.

Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U.

Cancer. 2003 Dec 25;99(6):365-71.

PMID:
14681945
20.
Items per page

Supplemental Content

Write to the Help Desk